M
Mark Dybul
Researcher at National Institutes of Health
Publications - 14
Citations - 3558
Mark Dybul is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Viral load. The author has an hindex of 13, co-authored 14 publications receiving 3469 citations.
Papers
More filters
Journal ArticleDOI
HIV preferentially infects HIV-specific CD4 + T cells
Daniel C. Douek,Jason M. Brenchley,Michael R. Betts,David R. Ambrozak,Brenna J. Hill,Yukari Okamoto,Joseph P. Casazza,Janaki Kuruppu,Kevin J. Kunstman,Steven M. Wolinsky,Zvi Grossman,Zvi Grossman,Mark Dybul,Annette Oxenius,David Price,Mark Connors,Richard A. Koup +16 more
TL;DR: The findings show that HIV-specific CD4+ T cells are preferentially infected by HIV in vivo, which provides a potential mechanism to explain the loss of HIV- specific CD4- T-cell responses, and consequently theloss of immunological control of HIV replication.
Journal ArticleDOI
Guidelines for using antiretroviral agents among HIV-infected adults and adolescents: The Panel on Clinical Practices for Treatment of HIV
TL;DR: This report provides pathogenesis-based rationale for therapeutic strategies as well as guidelines for implementing these strategies and recommends that, when possible, the treatment of HIV-infected patients should be directed by a clinician who has extensive experience in the care of these patients.
Journal ArticleDOI
Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy.
Tae-Wook Chun,Delphine Engel,Stephanie B. Mizell,Claire W. Hallahan,Fischette M,Park S,Richard T. Davey,Mark Dybul,J A Kovacs,J A Metcalf,JoAnn M. Mican,M. Michelle Berrey,Lawrence Corey,H C Lane,Anthony S. Fauci +14 more
TL;DR: Results indicate that the intermittent administration of IL-2 with continuous HAART may lead to a substantial reduction in the pool of resting CD4+ T cells that contain replication-competent HIV.
Journal ArticleDOI
Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
Drew Weissman,Ronald L. Rabin,James Arthos,Andrea Rubbert,Mark Dybul,Ruth Swofford,Sundararajan Venkatesan,Joshua M. Farber,Anthony S. Fauci +8 more
TL;DR: It is shown that recombinant envelope proteins from macrophage-tropic HIV and SIV induce a signal through CCR5 on CD4+ T cells and that envelope-mediated signal transduction through C CR5 induces chemotaxis of T cells.
Journal ArticleDOI
Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.
Susan Moir,Angela Malaspina,Oxana K. Pickeral,Eileen T. Donoghue,Joshua Vasquez,Natalie J. Miller,Surekha R. Krishnan,Marie A. Planta,John F. Turney,J. Shawn Justement,Shyamasundaran Kottilil,Mark Dybul,JoAnn M. Mican,Colin Kovacs,Tae-Wook Chun,Charles E. Birse,Anthony S. Fauci +16 more
TL;DR: It is demonstrated that altered expression of genes associated with IFN stimulation and terminal differentiation in B cells of HIV-viremic patients lead to an increased propensity to cell death, which may have substantial deleterious effects on B cell responsiveness to antigenic stimulation.